Sandhiya Balasubramaniyan

Sandhiya Balasubramaniyan is an experienced professional in product ownership and business analysis, currently serving as a Product Owner at Genesis Research Group since January 2022. Prior to this role, Sandhiya held various positions including Product Owner and Senior Business Analyst at Market Access Transformation, which is a subsidiary of Genesis Research, from September 2017 to November 2023. Sandhiya began the career at Multifonds, progressing through roles from Trainee to Team Lead from June 2011 to April 2017. Educational credentials include a Bachelor of Commerce in Accounting and Finance from St Joseph's College of Commerce and a Master of Business Administration in Finance from Acharya Institute of Technology.

Location

Amsterdam, Netherlands

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Market Access Transformation, a Genesis Research company

**May 2022 Genesis Research acquired Marketing Access Transformation** Founded in 2016, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange insights that asses the real-world potential of their pharmaceutical products. With close to 65 employees that span the US, UK and India, MAT is seen as a revolutionary company in the global pharmaceutical research space. Our primary platform, Rapid Payer Responses™ (RPR), enables pharmaceutical manufacturers to conduct critical market access research throughout the product and treatment development process. Through our global, vetted payer network, it is possible to gather more accurate, robust feedback and insights by probing further and asking deeper questions. you always have the exact answers you need in a fraction of the time and cost of a traditional payer research project. Our life science experts help facilitate this process, monitoring the responses in real time as they come in for quality and detail. Since the launch of Rapid Payer Response™ (RPR) in July 2016, we have partnered with over 50 of the leading pharmaceutical manufacturers, expanded our payer network to more than 45 countries and have achieved an impressive 93% license renewal rate as we continue to disrupt the older and outdated models for payer research. Were are diverse minded, global company with offices in the US (NJ, NY & CA), UK and India. If you are interested in joining our amazing MAT team, check our openings at https://www.marketaccesstransformation.com/careers


Employees

51-200

Links